Share this article
Share this article
RICHMOND, Va., April 22, 2021 /PRNewswire/ Indivior PLC (LON: INDV) today announced findings from a qualitative study examining the impact of COVID-19 on opioid use disorder (OUD) management and medication for opioid use disorder (MOUD) access in the U.S. which found that 85% of participants agreed that patients with OUD experienced more barriers to care during the COVID-19 pandemic.
1 Results from the study, entitled Impact of COVID-19 on OUD Management and MOUD Access in the US, were presented at the American Society of Addiction Medicine (ASAM) 2021 virtual meeting. The study was conducted to understand the impact of the COVID-19 pandemic on the management of OUD in the US from both provider and payer perspectives, as well as to gain insight into strategies adopted by healthcare organizations to overcome access barriers to OUD care and MOUD.
Chauvin Trial Verdict: All Roads Lead to 38th & Chicago
thenation.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thenation.com Daily Mail and Mail on Sunday newspapers.
윤석열 측 사임했지만 추미애 법무부 징계 부당 결판 보고 싶다
mt.co.kr - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from mt.co.kr Daily Mail and Mail on Sunday newspapers.
[단독] 윤석열 징계취소소송 끝까지 간다… 취하 안 한다
mt.co.kr - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from mt.co.kr Daily Mail and Mail on Sunday newspapers.